FBXL19 and acute myeloid leukemia: Sheng et al. demonstrated that the increased expression of FBXL19-AS1 in acute myeloid leukemia is related to clinicopathological factors, including cytogenetics (=0.021) and French-American-British classification (= 0.011) [60].